UBS Group Cuts Select Medical (NYSE:SEM) Price Target to $21.00

Select Medical (NYSE:SEM) had its price objective lowered by UBS Group from $40.00 to $21.00 in a research note issued to investors on Friday morning,Benzinga reports. UBS Group currently has a neutral rating on the health services provider’s stock.

SEM has been the subject of a number of other research reports. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Royal Bank of Canada increased their target price on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, December 30th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Select Medical has an average rating of “Hold” and an average price target of $39.50.

Select Medical Stock Down 2.1 %

NYSE SEM opened at $18.40 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a fifty-two week low of $18.02 and a fifty-two week high of $40.98. The business has a 50 day moving average price of $26.91 and a two-hundred day moving average price of $32.20. The stock has a market cap of $2.38 billion, a PE ratio of 8.60, a P/E/G ratio of 0.39 and a beta of 1.43.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the firm earned $0.46 earnings per share. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. As a group, sell-side analysts predict that Select Medical will post 1.97 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were given a $0.125 dividend. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 annualized dividend and a dividend yield of 2.72%. Select Medical’s payout ratio is 23.36%.

Insider Activity at Select Medical

In other news, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. This represents a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares in the company, valued at $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Institutional Trading of Select Medical

A number of large investors have recently modified their holdings of SEM. Quarry LP bought a new position in Select Medical in the 3rd quarter worth about $30,000. Canada Pension Plan Investment Board acquired a new position in shares of Select Medical during the second quarter worth approximately $39,000. DekaBank Deutsche Girozentrale bought a new position in Select Medical in the 2nd quarter worth approximately $60,000. GAMMA Investing LLC increased its position in Select Medical by 16.6% in the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after acquiring an additional 330 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new stake in Select Medical during the 3rd quarter valued at $81,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.